N
Norman J. Lewiston
Researcher at Stanford University
Publications - 80
Citations - 2719
Norman J. Lewiston is an academic researcher from Stanford University. The author has contributed to research in topics: Cystic fibrosis & Lung transplantation. The author has an hindex of 32, co-authored 80 publications receiving 2677 citations. Previous affiliations of Norman J. Lewiston include Grant Medical Center & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis.
Mordechai R. Kramer,David W. Denning,Sara E. Marshall,David J. Ross,Gerald J. Berry,Norman J. Lewiston,David A. Stevens,James Theodore +7 more
TL;DR: This apparently new form of invasive disease is initially limited to the anastomosis site and large airways and a classification of the various forms of saprophytic, allergic, and invasive forms of aspergillus tracheobronchitis, to include this new entity, is proposed.
Journal ArticleDOI
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole
TL;DR: It is concluded that oral itraconazole may be an effective adjunctive therapy in ABPA, possibly by clearing the airway of Aspergillus, and that randomized trials of this agent are warranted to better define its usefulness in this disorder.
Journal ArticleDOI
Cyclosporine and Itraconazole Interaction in Heart and Lung Transplant Recipients
Mordechai R. Kramer,Sara E. Marshall,David W. Denning,Anne Keogh,Richard M. Tucker,John N. Galgiani,Norman J. Lewiston,David A. Stevens,James Theodore +8 more
TL;DR: Itraconazole is a new triazole antifungal that is particularly appropriate in patients receiving cyclosporine therapy, in whom nephrotoxicity is ...
Journal ArticleDOI
Fatal myocardial toxicity during continuous infusion intravenous isoproterenol therapy of asthma.
TL;DR: The vulnerability of the hypoxic myocardium to the effects of isoproterenol suggests that careful cardiac monitoring is essential in the management of patients receiving this medication for treatment of respiratory failure secondary to severe asthma.
Journal ArticleDOI
Current trends in lung transplantation. Lobar transplantation and expanded use of single lungs.
Vaughn A. Starnes,Norman J. Lewiston,Helen Luikart,James Theodore,Edward B. Stinson,Norman E. Shumway +5 more
TL;DR: Single lung transplantation is an effective therapeutic option for selected patients with vascular or parenchymal lung disease and expanding indications will permit more individuals to receive transplants from the existing donor pool.